ImmuPharma PLC
IMM
Company Profile
Business description
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease.
Contact
One Bartholomew Close
LondonEC1A 7BL
GBRT: +44 2072062650
E: investors@immupharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
3
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,032.40 | 100.70 | -1.24% |
| CAC 40 | 7,858.83 | 17.53 | -0.22% |
| DAX 40 | 22,390.84 | 149.14 | -0.66% |
| Dow JONES (US) | 42,225.32 | 235.36 | 0.56% |
| FTSE 100 | 8,608.48 | 26.32 | -0.30% |
| HKSE | 22,883.92 | 318.61 | -1.37% |
| NASDAQ | 17,601.05 | 151.16 | 0.87% |
| Nikkei 225 | 34,686.45 | 1,039.42 | -2.91% |
| NZX 50 Index | 12,252.77 | 67.42 | -0.55% |
| S&P 500 | 5,670.97 | 37.90 | 0.67% |
| S&P/ASX 200 | 7,838.20 | 96.30 | -1.21% |
| SSE Composite Index | 3,345.24 | 4.88 | -0.15% |